69 related articles for article (PubMed ID: 9369430)
1. Establishment and characterization of a new erythropoietin-dependent acute myeloid leukemia cell line, AS-E2.
Miyazaki Y; Kuriyama K; Higuchi M; Tsushima H; Sohda H; Imai N; Saito M; Kondo T; Tomonaga M
Leukemia; 1997 Nov; 11(11):1941-9. PubMed ID: 9369430
[TBL] [Abstract][Full Text] [Related]
2. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
[TBL] [Abstract][Full Text] [Related]
3. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
4. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor.
Klingmüller U
Eur J Biochem; 1997 Nov; 249(3):637-47. PubMed ID: 9395308
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
6. Effect of the interaction between transforming growth factor beta and erythropoietin on the proliferation of normal erythroid progenitors and leukemic UT-7 cells: action of transforming growth factor beta on the erythropoietin receptor.
Leveque E; Nagel MD; Haye B
Hematol Oncol; 1996 Sep; 14(3):137-46. PubMed ID: 9119358
[TBL] [Abstract][Full Text] [Related]
7. Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2.
Tsushima H; Urata Y; Miyazaki Y; Fuchigami K; Kuriyama K; Kondo T; Tomonaga M
Cell Growth Differ; 1997 Dec; 8(12):1317-28. PubMed ID: 9419420
[TBL] [Abstract][Full Text] [Related]
8. Spleen tyrosine kinase mediates the actions of EPO and GM-CSF and coordinates with TGF-β in erythropoiesis.
Chang HC; Huang DY; Wu MS; Chu CL; Tzeng SJ; Lin WW
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):687-696. PubMed ID: 28131718
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of a novel CD34-positive human myeloid leukemia cell line: MHH225 growing in serum-free culture.
Hassan HT; Petershofen E; Lux E; Fonatsch C; Heil G; Freund M
Ann Hematol; 1995 Sep; 71(3):111-7. PubMed ID: 7548328
[TBL] [Abstract][Full Text] [Related]
10. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-mediated erythroid maturation in megakaryoblastic human cell line HU-3.
Morgan DA; Class R; Soslau G; Brodsky I
Exp Hematol; 1997 Dec; 25(13):1378-85. PubMed ID: 9406997
[TBL] [Abstract][Full Text] [Related]
12. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7.
Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR
Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
14. Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34++CD33-or low cord blood cells on cytokine-stimulated erythroid colony formation.
Lu L; Ge Y; Li ZH; Xiao M; Broxmeyer HE
Exp Hematol; 1996 Feb; 24(2):347-51. PubMed ID: 8641364
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
[TBL] [Abstract][Full Text] [Related]
16. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
17. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
18. Effect of Tumor Necrosis Factor-Alpha on Erythropoietin and Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β-Thalassemia/Hemoglobin E Patients.
Tanyong DI; Panichob P; Kheansaard W; Fucharoen S
Turk J Haematol; 2015 Dec; 32(4):304-10. PubMed ID: 26376749
[TBL] [Abstract][Full Text] [Related]
19. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.
Witthuhn BA; Quelle FW; Silvennoinen O; Yi T; Tang B; Miura O; Ihle JN
Cell; 1993 Jul; 74(2):227-36. PubMed ID: 8343951
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
